Condition
Intertrochanteric Femur Fracture
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
Early P 1 (1)
Trial Status
Not Yet Recruiting1
Active Not Recruiting1
Enrolling By Invitation1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07607886Active Not RecruitingPrimary
Inflammatory Indices, Early Mortality, and ICU Stay in Geriatric PFN Patients
NCT07567339Not ApplicableNot Yet Recruiting
How TENS Affects Pain, Medication Use, and Muscle Function in Older Adults With Hip Fractures
NCT07179042Early Phase 1Enrolling By InvitationPrimary
Intertrochanteric Femur Fracture Patients Who Receive Metformin With a Placebo
Showing all 3 trials